Article Sidebar

PDF
Date Published: 18/10/2021
Abstract Views: 308
Views PDF: 145
DOI: https://doi.org/10.51298/vmj.v506i1.1202
Issue
Vol. 506 No. 1 (2021)
Section
Các bài báo
How to Cite
Phương Linh, N. ., & Văn Tuấn, N. . (2021). SEXUAL DYSFUNCTION IN DEPRESSED FEMALES RECEIVING SELECTIVE SEROTONIN REUPTAKE INHIBITORS. Vietnam Medical Journal, 506(1). https://doi.org/10.51298/vmj.v506i1.1202

SEXUAL DYSFUNCTION IN DEPRESSED FEMALES RECEIVING SELECTIVE SEROTONIN REUPTAKE INHIBITORS

Nguyễn Phương Linh1,, Nguyễn Văn Tuấn2
1 National Mental Health Institute, Bach Mai Hospital
2 Hanoi Medical University

Main Article Content

Abstract

Background:  Sexual dysfunction is a common problem in depressed female patients receiving selective serotonin reuptake inhibitors (SSRIs). However, in Vietnam, there have been no studies on this issue, although it seriously affects treatment adherence as well as quality of life and the cost of medical services later. Research objectives: To evaluate side-effect on sexual dysfunction in female patients with depression treated with SSRIs at the National Institute of Mental Health. Subjects and methods: A cross-sectional descriptive study at 3 times of 58 depressed female patients treated with SSRIs at the National Institute of Mental Health from September 2020 to July 2021, using the Female Sexual Function Index (FSFI). Results: the general age of the group with sexual dysfunction was 39.23 ± 12.69 years. Pain during vaginal penetration accounted for the highest percentage with 89.66% and the lowest was vaginal lubrication with 67.24%. The mean FSFI score decreased from 20.42±5.95 to 13.56±4.34 demonstrating a statistically significant decline with p <0.01 at both time points after 2 weeks and after 4 weeks of treatment. Conclusion: The most common sexual dysfunction in depressed female patients treated with SSRIs was pain during vaginal penetration. The decline was statistically significant with p<0.01 after 4 weeks of treatment.

Article Details

Keywords

Female sexual dysfunction, selective serotonin reuptake inhibitors

References

1. Hu XH, Hunkeler EM, Fireman B. Incidence and Duration of Side Effects and Those Rated as Bothersome With Selective Serotonin Reuptake Inhibitor Treatment for Depression: Patient Report Versus Physician Estimate. Published online 2004:7.
2. Rosenberg KP, Bleiberg KL, Koscis J, Gross C. A Survey of Sexual Side Effects Among Severely Mentally Ill Patients Taking Psychotropic Medications: Impact on Compliance. Journal of Sex & Marital Therapy. 2003;29(4):289-296.
3. Masiran R, Sidi H, Mohamed Z, et al. Female Sexual Dysfunction in Patients with Major Depressive Disorder (MDD) Treated with Selective Serotonin Reuptake Inhibitor (SSRI) and Its Association with S erotonin 2A—1438 G/A Single Nucleotide Polymorphisms. The Journal of Sexual Medicine. 2014;11(4):1047-1055.
4. Hayes R, Dennerstein L. The Impact of Aging on Sexual Function and Sexual Dysfunction in Women: A Review of Population‐Based Studies. The Journal of Sexual Medicine. 2005;2(3):317-330.
5. Shaeer O, Skakke D, Giraldi A, Shaeer E, Shaeer K. Female Orgasm and Overall Sexual Function and Habits: A Descriptive Study of a Cohort of U.S. Women. The Journal of Sexual Medicine. 2020;17(6):1133-1143.
6. Basson R, Gilks T. Women’s sexual dysfunction associated with psychiatric disorders and their treatment. Womens Health (Lond Engl). 2018;14:174550651876266.
7. Grover S, Kate N, Mishra E, Avasthi A. Prevalence and Type of Sexual Dysfunction in Female Patients Receiving Antidepressant Medications. Journal of Psychosexual Health. 2020;2(2):158-164.
8. Grover S, Shah R, Dutt A, Avasthi A. Prevalence and pattern of sexual dysfunction in married females receiving antidepressants: An exploratory study. J Pharmacol Pharmacother. 2012;3(3):259.